BFM
RCEL icon

Boothbay Fund Management’s Avita Medical RCEL Stock Holding History

Boothbay Fund Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-27,716
Closed -$387K – 2219
2023
Q1 		$387K Buy
+27,716
New +$295K 0.01% 1374

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Boothbay Fund Management's RCEL Position: Q2 2023 in Review

Boothbay Fund Management sold out of Avita Medical (RCEL) in Q2 2023, closing a stake of 27,716 shares — an estimated $387K sold.

Boothbay Fund Management first reported a position in RCEL in Q1 2023 and held it in 1 quarter. The position peaked at $387K in Q1 2023. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2023.

  • Boothbay Fund Management reported no remaining Avita Medical position as of Q2 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 27,716 Avita Medical shares in Q2 2023, an estimated $387K.
  • Boothbay Fund Management first reported a position in Avita Medical in Q1 2023 and held it in 1 quarter.
  • Boothbay Fund Management's Avita Medical position peaked at $387K in Q1 2023.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.